Keisha N. Hardeman

发表

Abstract 670: Molecular basis of the idling state uncovers vulnerabilities suitable to sequential targeting in melanoma

Corey E. Hayford, Bishal B. Paudel, Leonard A. Harris, 2019 .

Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition

Bishal B. Paudel, Keisha N. Hardeman, Darren R. Tyson, 2017, Scientific Reports.

Subscriptions Subscriptions Subscriptions Subscriptions Subscriptions Editor-in-chief

Keisha N. Hardeman, M. Henry, A. Cubero, 2002 .

An unbiased metric of antiproliferative drug effect in vitro

Carlos F. Lopez, Keisha N. Hardeman, L. A. Harris, 2016, Nature Methods.

Quantifying Drug Combination Synergy along Potency and Efficacy Axes.

Keisha N. Hardeman, Vito Quaranta, Leonard A Harris, 2019, Cell systems.

Drug-Tolerant Idling Melanoma Cells Exhibit Theory-Predicted Metabolic Low-Low Phenotype

Corey E. Hayford, Keisha N. Hardeman, J. Onuchic, 2020, Frontiers in Oncology.

Drug-Tolerant Idling Melanoma Cells Exhibit Theory-Predicted Metabolic Low-Low Phenotype

Corey E. Hayford, Keisha N. Hardeman, J. Onuchic, 2019, bioRxiv.

Manganese-induced mitochondrial dysfunction is not detectable at exposures below the acute cytotoxic threshold in neuronal cell types.

Keisha N. Hardeman, M. Aschner, Aaron B. Bowman, 2020, Toxicological sciences : an official journal of the Society of Toxicology.

A Nonquiescent "Idling" Population State in Drug-Treated, BRAF-Mutated Melanoma.

Corey E. Hayford, Keisha N. Hardeman, L. A. Harris, 2018, Biophysical journal.

An Integrative Gene Expression and Mathematical Flux Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells

Joshua E. Lewis, Corey E. Hayford, Keisha N. Hardeman, 2020, Cancer Research.

Disruption of Redox Balance Enhances the Effects of BRAF-inhibition in Melanoma Cells

Joshua E. Lewis, Corey E. Hayford, Keisha N. Hardeman, 2019, bioRxiv.